Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie E Oomens

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
JAMA Psychiatry|May 21, 2025
Depression and Amyloid Pathology-Methodological Aspects-ReplyWietse A Wiels, Julie E Oomens, Willemijn J Jansen
Journal of Alzheimer'S Disease : JAD|May 30, 2026
Longitudinal amyloid PET changes by cerebrospinal fluid amyloid and tau profiles in individuals with normal cognition: Role of <i>APOE</i> ε4Marianna Rizzo, Julie E Oomens, Willemijn J Jansen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 12, 2026
BiomarkersJulie E Oomens, Theresa M Harrison, Jeffrey L Dage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersStephan Duijkers, Inez H G B Ramakers, Kim Massloh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2025
Lifestyle, genetic risk, plasma pTau217, and incident cognitive impairment in WRAPRachel L Studer, Karly A Cody, Julie E Oomens, et al.
Medrxiv : the Preprint Server for Health Sciences|December 9, 2024
Targeted Proteomic Biomarker Profiling Using NULISA in a cohort enriched with risk for Alzheimer's Disease and Related DementiasRamiro Eduardo Rea Reyes, Rachael E Wilson, Rebecca E Langhough, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 17, 2025
Late-midlife lifestyle and brain and cognitive changes in individuals on the AD versus non-AD continuumJulie E Oomens, Karly A Cody, Lianlian Du, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2025
Targeted proteomic biomarker profiling using NULISA in a cohort enriched with risk for Alzheimer's disease and related dementiasRamiro Eduardo Rea Reyes, Rachael E Wilson, Rebecca E Langhough, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersRamiro Eduardo Rea Reyes, Rachael E Wilson, Julie E Oomens, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 21, 2024
Biomarkers of endothelial dysfunction and cognition: A two-step IPD meta-analysisMagdalena Beran, Willemijn J Jansen, Julie E Oomens, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
JAMA Psychiatry|May 21, 2025
Depression and Amyloid Pathology-Methodological Aspects-ReplyWietse A Wiels, Julie E Oomens, Willemijn J Jansen
Journal of Alzheimer'S Disease : JAD|May 30, 2026
Longitudinal amyloid PET changes by cerebrospinal fluid amyloid and tau profiles in individuals with normal cognition: Role of <i>APOE</i> ε4Marianna Rizzo, Julie E Oomens, Willemijn J Jansen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 12, 2026
BiomarkersJulie E Oomens, Theresa M Harrison, Jeffrey L Dage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersStephan Duijkers, Inez H G B Ramakers, Kim Massloh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2025
Lifestyle, genetic risk, plasma pTau217, and incident cognitive impairment in WRAPRachel L Studer, Karly A Cody, Julie E Oomens, et al.
Medrxiv : the Preprint Server for Health Sciences|December 9, 2024
Targeted Proteomic Biomarker Profiling Using NULISA in a cohort enriched with risk for Alzheimer's Disease and Related DementiasRamiro Eduardo Rea Reyes, Rachael E Wilson, Rebecca E Langhough, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 17, 2025
Late-midlife lifestyle and brain and cognitive changes in individuals on the AD versus non-AD continuumJulie E Oomens, Karly A Cody, Lianlian Du, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2025
Targeted proteomic biomarker profiling using NULISA in a cohort enriched with risk for Alzheimer's disease and related dementiasRamiro Eduardo Rea Reyes, Rachael E Wilson, Rebecca E Langhough, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersRamiro Eduardo Rea Reyes, Rachael E Wilson, Julie E Oomens, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 21, 2024
Biomarkers of endothelial dysfunction and cognition: A two-step IPD meta-analysisMagdalena Beran, Willemijn J Jansen, Julie E Oomens, et al.
Pageof 2